InsidersTradesSigma
Follow the 안트로젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 안트로젠 has recorded 1 insider filings. Market capitalisation: €162.8bn. The latest transaction was filed on 21 April 2026 (Purchase). Among the most active insiders: 이엠텍. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
안트로젠 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de terapias biológicas y medicamentos innovadores.